Rodler E, Sharma P, Barlow WE, Gralow JR, et al. Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Oncol 2023 Jan 6:S1470-2045(22)00739.
PMID: 36623515